Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Reijneveld, J.C.; Taphoorn, M.J.B.; Coens, C.; Bromberg, J.E.C.; Mason, W.P.; Hoang-Xuan, K.; ... ; Baumert, B.G. (2016)

Article / Letter to editor

• All authors: Reijneveld, J.C.; Taphoorn, M.J.B.; Coens, C.; Bromberg, J.E.C.; Mason, W.P.; Hoang-Xuan, K.; Ryan, G.; Hassel, M. ben; Enting, R.H.; Brandes, A.A.; Wick, A.; Chinot, O.; Reni, M.; Kantor, G.; Thiessen, B.; Klein, M.; Verger, E.; Borchers, C.; Hau, P.; Back, M.; Smits, A.; Golfinopoulos, V.; Gorlia, T.; Bottomley, A.; Stupp, R.; Baumert, B.G.
• Date: 2016-11-30
• Journal: The Lancet Oncology
• Volume: 17
• Issue: 11
• Pages: 1533 - 1542
• DOI: doi:10.1016/S1470-2045(16)30305-9